Trial Review

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/ct2/show/NCT03383458




Registration number
NCT03383458
Ethics application status
Date submitted
21/12/2017
Date registered
26/12/2017
Date last updated
18/11/2023

Titles & IDs
Public title
A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation
Scientific title
A Phase 3, Randomized, Double-blind Study of Adjuvant Nivolumab Versus Placebo for Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation
Secondary ID [1] 0 0
CA209-9DX
Universal Trial Number (UTN)
Trial acronym
CheckMate 9DX
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Hepatocellular Carcinoma 0 0
Liver Cancer 0 0
Condition category
Condition code
Cancer 0 0 0 0
Non melanoma skin cancer
Cancer 0 0 0 0
Kidney
Cancer 0 0 0 0
Liver
Other 0 0 0 0
Research that is not of generic health relevance and not applicable to specific health categories listed above

Intervention/exposure
Study type
Interventional(has expanded access)
Description of intervention(s) / exposure
Other interventions - Nivolumab
Other interventions - Placebo

Experimental: Arm A -

Placebo Comparator: Arm B -


Other interventions: Nivolumab
Specified dose on specified days

Other interventions: Placebo
specified dose on specified days
Intervention code [1] 0 0
Other interventions
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Recurrence-free Survival (RFS)
Timepoint [1] 0 0
Up to 49 months
Secondary outcome [1] 0 0
Overall Survival (OS)
Timepoint [1] 0 0
Up to 7 years
Secondary outcome [2] 0 0
Time to recurrence (TTR)
Timepoint [2] 0 0
Up to 49 months

Eligibility
Key inclusion criteria
- Participants with a first diagnosis of HCC who have undergone a curative resection or
ablation

- Participants are eligible to enroll if they have non-viral related-HCC, or if they
have HBV-HCC, or HCV-HCC

- Child-Pugh Score 5 or 6

- Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0 or 1
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
- Known fibrolamellar HCC, sarcomatoid HCC, or mixed cholangiocarcinoma and HCC

- Any evidence of tumor metastasis or co-existing malignant disease

- Participants previously receiving any prior therapy for HCC, including loco-regional
therapies

- Participants who have undergone a liver transplant or those who are in the waiting
list for liver transplantation

- Participants who have received a live/attenuated vaccine within 30 days of
randomization (eg, varicella, zoster, yellow fever, rotavirus, oral polio and measles,
mumps, rubella [MMR]).

Other protocol defined inclusion/exclusion criteria apply

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?
The people receiving the treatment/s
The people administering the treatment/s
The people assessing the outcomes
The people analysing the results/data
Intervention assignment
Parallel
Other design features
Phase
Phase 3
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Active, not recruiting
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
18/04/2018
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
16/12/2025
Actual
Sample size
Target
Accrual to date
Final
545
Recruitment in Australia
Recruitment state(s)
NSW,QLD,SA,VIC,WA
Recruitment hospital [1] 0 0
Local Institution - 0239 - Blacktown
Recruitment hospital [2] 0 0
Local Institution - 0166 - Camperdown
Recruitment hospital [3] 0 0
Local Institution - 0141 - Concord
Recruitment hospital [4] 0 0
Local Institution - 0220 - Herston
Recruitment hospital [5] 0 0
Local Institution - 0164 - Adelaide
Recruitment hospital [6] 0 0
Local Institution - 0224 - Heidelberg
Recruitment hospital [7] 0 0
Local Institution - 0124 - Nedlands
Recruitment postcode(s) [1] 0 0
2148 - Blacktown
Recruitment postcode(s) [2] 0 0
2050 - Camperdown
Recruitment postcode(s) [3] 0 0
2139 - Concord
Recruitment postcode(s) [4] 0 0
4029 - Herston
Recruitment postcode(s) [5] 0 0
5000 - Adelaide
Recruitment postcode(s) [6] 0 0
3084 - Heidelberg
Recruitment postcode(s) [7] 0 0
6009 - Nedlands
Recruitment outside Australia
Country [1] 0 0
United States of America
State/province [1] 0 0
Alabama
Country [2] 0 0
United States of America
State/province [2] 0 0
Arizona
Country [3] 0 0
United States of America
State/province [3] 0 0
California
Country [4] 0 0
United States of America
State/province [4] 0 0
Colorado
Country [5] 0 0
United States of America
State/province [5] 0 0
Florida
Country [6] 0 0
United States of America
State/province [6] 0 0
Georgia
Country [7] 0 0
United States of America
State/province [7] 0 0
Kansas
Country [8] 0 0
United States of America
State/province [8] 0 0
Louisiana
Country [9] 0 0
United States of America
State/province [9] 0 0
Michigan
Country [10] 0 0
United States of America
State/province [10] 0 0
Minnesota
Country [11] 0 0
United States of America
State/province [11] 0 0
Missouri
Country [12] 0 0
United States of America
State/province [12] 0 0
New York
Country [13] 0 0
United States of America
State/province [13] 0 0
Ohio
Country [14] 0 0
United States of America
State/province [14] 0 0
Oregon
Country [15] 0 0
United States of America
State/province [15] 0 0
Texas
Country [16] 0 0
United States of America
State/province [16] 0 0
Virginia
Country [17] 0 0
United States of America
State/province [17] 0 0
Washington
Country [18] 0 0
Argentina
State/province [18] 0 0
Buenos Aires
Country [19] 0 0
Argentina
State/province [19] 0 0
Santa FE
Country [20] 0 0
Austria
State/province [20] 0 0
Graz
Country [21] 0 0
Austria
State/province [21] 0 0
Vienna
Country [22] 0 0
Austria
State/province [22] 0 0
Wien
Country [23] 0 0
Belgium
State/province [23] 0 0
Brussels
Country [24] 0 0
Belgium
State/province [24] 0 0
Bruxelles
Country [25] 0 0
Belgium
State/province [25] 0 0
Edegem
Country [26] 0 0
Belgium
State/province [26] 0 0
Gent
Country [27] 0 0
Belgium
State/province [27] 0 0
Leuven
Country [28] 0 0
Brazil
State/province [28] 0 0
Minas Gerais
Country [29] 0 0
Brazil
State/province [29] 0 0
Sao Paulo
Country [30] 0 0
Brazil
State/province [30] 0 0
SAO Paulo
Country [31] 0 0
Canada
State/province [31] 0 0
Alberta
Country [32] 0 0
Canada
State/province [32] 0 0
Edmonton
Country [33] 0 0
Chile
State/province [33] 0 0
Metropolitana
Country [34] 0 0
Chile
State/province [34] 0 0
Región Metropolitana De Santiago
Country [35] 0 0
Chile
State/province [35] 0 0
Valparaiso
Country [36] 0 0
Colombia
State/province [36] 0 0
Bogota
Country [37] 0 0
France
State/province [37] 0 0
Bobigny
Country [38] 0 0
France
State/province [38] 0 0
Brest
Country [39] 0 0
France
State/province [39] 0 0
Clermont Ferrand
Country [40] 0 0
France
State/province [40] 0 0
Clichy
Country [41] 0 0
France
State/province [41] 0 0
Creteil Cedex
Country [42] 0 0
France
State/province [42] 0 0
Grenoble Cedex 09
Country [43] 0 0
France
State/province [43] 0 0
Lille
Country [44] 0 0
France
State/province [44] 0 0
Lyon Cedex 04
Country [45] 0 0
France
State/province [45] 0 0
Montpellier Cedex
Country [46] 0 0
France
State/province [46] 0 0
Nice
Country [47] 0 0
France
State/province [47] 0 0
Poitiers
Country [48] 0 0
France
State/province [48] 0 0
Reims
Country [49] 0 0
France
State/province [49] 0 0
Rennes Cedex 9
Country [50] 0 0
France
State/province [50] 0 0
Saint-Priest-en-Jarez
Country [51] 0 0
France
State/province [51] 0 0
Vandoeuvre Les Nancy Cedex
Country [52] 0 0
France
State/province [52] 0 0
Villejuif
Country [53] 0 0
Germany
State/province [53] 0 0
Aachen
Country [54] 0 0
Germany
State/province [54] 0 0
Berlin
Country [55] 0 0
Germany
State/province [55] 0 0
Bonn
Country [56] 0 0
Germany
State/province [56] 0 0
Essen
Country [57] 0 0
Germany
State/province [57] 0 0
Frankfurt am Main
Country [58] 0 0
Germany
State/province [58] 0 0
Hannover
Country [59] 0 0
Germany
State/province [59] 0 0
Homburg
Country [60] 0 0
Germany
State/province [60] 0 0
Koln
Country [61] 0 0
Germany
State/province [61] 0 0
Leipzig
Country [62] 0 0
Germany
State/province [62] 0 0
Magdeburg
Country [63] 0 0
Germany
State/province [63] 0 0
Mainz
Country [64] 0 0
Germany
State/province [64] 0 0
Mannheim
Country [65] 0 0
Germany
State/province [65] 0 0
Muenchen
Country [66] 0 0
Germany
State/province [66] 0 0
Tuebingen
Country [67] 0 0
Germany
State/province [67] 0 0
Wuerzburg
Country [68] 0 0
Hong Kong
State/province [68] 0 0
Hong Kong
Country [69] 0 0
Italy
State/province [69] 0 0
ME
Country [70] 0 0
Italy
State/province [70] 0 0
Bologna
Country [71] 0 0
Italy
State/province [71] 0 0
Firenze
Country [72] 0 0
Italy
State/province [72] 0 0
Meldola
Country [73] 0 0
Italy
State/province [73] 0 0
Milano
Country [74] 0 0
Italy
State/province [74] 0 0
Modena
Country [75] 0 0
Italy
State/province [75] 0 0
Monserrato
Country [76] 0 0
Italy
State/province [76] 0 0
Napoli
Country [77] 0 0
Italy
State/province [77] 0 0
Padova
Country [78] 0 0
Italy
State/province [78] 0 0
Rome
Country [79] 0 0
Japan
State/province [79] 0 0
Chiba
Country [80] 0 0
Japan
State/province [80] 0 0
Fukuoka
Country [81] 0 0
Japan
State/province [81] 0 0
Hokkaido
Country [82] 0 0
Japan
State/province [82] 0 0
Hyogo
Country [83] 0 0
Japan
State/province [83] 0 0
Ishikawa
Country [84] 0 0
Japan
State/province [84] 0 0
Iwate
Country [85] 0 0
Japan
State/province [85] 0 0
Kumamoto
Country [86] 0 0
Japan
State/province [86] 0 0
Osaka
Country [87] 0 0
Japan
State/province [87] 0 0
Tokushima
Country [88] 0 0
Japan
State/province [88] 0 0
Tokyo
Country [89] 0 0
Japan
State/province [89] 0 0
Hiroshima
Country [90] 0 0
Japan
State/province [90] 0 0
Kanagawa
Country [91] 0 0
Korea, Republic of
State/province [91] 0 0
Gyeonggi-do
Country [92] 0 0
Korea, Republic of
State/province [92] 0 0
Seoul-teukbyeolsi [Seoul]
Country [93] 0 0
Korea, Republic of
State/province [93] 0 0
Daegu
Country [94] 0 0
Korea, Republic of
State/province [94] 0 0
Goyang-si
Country [95] 0 0
Korea, Republic of
State/province [95] 0 0
Gyeongsangnam-do
Country [96] 0 0
Korea, Republic of
State/province [96] 0 0
Jeollanam-do
Country [97] 0 0
Korea, Republic of
State/province [97] 0 0
Seongnam-si
Country [98] 0 0
Korea, Republic of
State/province [98] 0 0
Seoul
Country [99] 0 0
Mexico
State/province [99] 0 0
Durango
Country [100] 0 0
Mexico
State/province [100] 0 0
Nuevo Leon
Country [101] 0 0
Mexico
State/province [101] 0 0
Nuevo León
Country [102] 0 0
Mexico
State/province [102] 0 0
San Luis Potosi
Country [103] 0 0
Netherlands
State/province [103] 0 0
Maastricht
Country [104] 0 0
Netherlands
State/province [104] 0 0
Utrecht
Country [105] 0 0
New Zealand
State/province [105] 0 0
Auckland
Country [106] 0 0
Puerto Rico
State/province [106] 0 0
San Juan
Country [107] 0 0
Romania
State/province [107] 0 0
Brasov
Country [108] 0 0
Romania
State/province [108] 0 0
Bucharest
Country [109] 0 0
Romania
State/province [109] 0 0
Cluj-Napoca
Country [110] 0 0
Romania
State/province [110] 0 0
Constanta
Country [111] 0 0
Romania
State/province [111] 0 0
Craiova
Country [112] 0 0
Romania
State/province [112] 0 0
Timisoara
Country [113] 0 0
Russian Federation
State/province [113] 0 0
Sankt-Peterburg
Country [114] 0 0
Russian Federation
State/province [114] 0 0
Arkhangelsk
Country [115] 0 0
Russian Federation
State/province [115] 0 0
Leningrad Region
Country [116] 0 0
Russian Federation
State/province [116] 0 0
Moscow
Country [117] 0 0
Singapore
State/province [117] 0 0
Singapore
Country [118] 0 0
Spain
State/province [118] 0 0
Barcelona
Country [119] 0 0
Spain
State/province [119] 0 0
Córdoba
Country [120] 0 0
Spain
State/province [120] 0 0
Donostia-San Sebastian
Country [121] 0 0
Spain
State/province [121] 0 0
Madrid
Country [122] 0 0
Spain
State/province [122] 0 0
Pamplona
Country [123] 0 0
Spain
State/province [123] 0 0
Sabadell (Barcelona)
Country [124] 0 0
Spain
State/province [124] 0 0
Sevilla
Country [125] 0 0
Spain
State/province [125] 0 0
Valencia
Country [126] 0 0
Spain
State/province [126] 0 0
Zaragoza
Country [127] 0 0
Taiwan
State/province [127] 0 0
TNN
Country [128] 0 0
Taiwan
State/province [128] 0 0
Kaohsiung
Country [129] 0 0
Taiwan
State/province [129] 0 0
Taichung
Country [130] 0 0
Taiwan
State/province [130] 0 0
Tainan
Country [131] 0 0
Taiwan
State/province [131] 0 0
Taipei
Country [132] 0 0
Taiwan
State/province [132] 0 0
Taoyuan
Country [133] 0 0
Taiwan
State/province [133] 0 0
Yunlin
Country [134] 0 0
United Kingdom
State/province [134] 0 0
London
Country [135] 0 0
United Kingdom
State/province [135] 0 0
Manchester
Country [136] 0 0
United Kingdom
State/province [136] 0 0
Wirral

Funding & Sponsors
Primary sponsor type
Commercial sector/Industry
Name
Bristol-Myers Squibb
Address
Country
Other collaborator category [1] 0 0
Commercial sector/Industry
Name [1] 0 0
Ono Pharmaceutical Co. Ltd
Address [1] 0 0
Country [1] 0 0

Ethics approval
Ethics application status

Summary
Brief summary
This study will investigate if nivolumab will improve recurrence-free survival (RFS) compared
to placebo in participants with HCC who have undergone complete resection or have achieved a
complete response after local ablation, and who are at high risk of recurrence
Trial website
https://clinicaltrials.gov/ct2/show/NCT03383458
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Bristol-Myers Squibb
Address 0 0
Bristol-Myers Squibb
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries



Summary Results

For IPD and results data, please see https://clinicaltrials.gov/ct2/show/NCT03383458